These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37738211)

  • 1. Aging-Related Mitochondrial Dysfunction Is Associated With Fibrosis in Benign Prostatic Hyperplasia.
    Adrian AE; Liu TT; Pascal LE; Bauer SR; DeFranco DB; Ricke WA
    J Gerontol A Biol Sci Med Sci; 2024 Jun; 79(6):. PubMed ID: 37738211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostatic hyperplasia nodules in patients treated with celecoxib and/or finasteride have reduced levels of NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, a mitochondrial protein essential for efficient function of the electron transport chain.
    Liu TT; Igarashi T; El-Khoury N; Ihejirika N; Paxton K; Jaumotte J; Dhir R; Hudson CN; Nelson JB; DeFranco DB; Yoshimura N; Wang Z; Pascal LE
    Prostate; 2024 Oct; 84(14):1309-1319. PubMed ID: 39004950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
    Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
    Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-Dependent Effects of Voluntary Wheel Running Exercise on Voiding Behavior and Potential Age-Related Molecular Mechanisms in Mice.
    Liu TT; Pascal LE; Bauer SR; Miles HN; Panksepp JB; Lloyd GL; Li L; DeFranco DB; Ricke WA
    J Gerontol A Biol Sci Med Sci; 2024 Jun; 79(6):. PubMed ID: 38198648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
    Inamura S; Shinagawa T; Hoshino H; Sakai Y; Imamura Y; Yokoyama O; Kobayashi M
    Prostate; 2017 May; 77(7):794-802. PubMed ID: 28181681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Holter Monitoring (24-Hour ECG) Parameter Dynamics in Patients with Ischemic Heart Disease and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
    Fiev DN; Vinarov AZ; Tsarichenko DG; Kopylov PY; Demidko YL; Syrkin AL; Rapoport LM; Alyaev YG; Glybochko PV
    Adv Ther; 2019 Aug; 36(8):2072-2085. PubMed ID: 31148056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens and estrogens in benign prostatic hyperplasia: past, present and future.
    Nicholson TM; Ricke WA
    Differentiation; 2011; 82(4-5):184-99. PubMed ID: 21620560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and Emerging Technologies in Treatment of Lower Urinary Tract Symptoms From Benign Prostatic Hyperplasia.
    Gupta NK; Gange SN; McVary KT
    Sex Med Rev; 2019 Jul; 7(3):491-498. PubMed ID: 29606553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
    Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
    BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.
    Inamura S; Ito H; Shinagawa T; Tsutsumiuchi M; Taga M; Kobayashi M; Yokoyama O
    Prostate; 2018 Jul; 78(10):743-752. PubMed ID: 29608020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines and BPH/LUTS.
    Macoska JA
    Differentiation; 2011; 82(4-5):253-60. PubMed ID: 21600689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between anogenital distance and benign prostatic hyperplasia related lower urinary tract symptoms in Chinese aging men.
    Lu Y; Fan S; Song Y; Liu K; Zhou K; Kang J; Wang S; Yang Y; Liu X
    World J Urol; 2021 Jul; 39(7):2645-2653. PubMed ID: 33141318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.
    Jiang M; Strand DW; Franco OE; Clark PE; Hayward SW
    Differentiation; 2011; 82(4-5):220-36. PubMed ID: 21645960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR2
    Popovics P; Silver SV; Uchtmann KS; Arendt LM; Vezina CM; Ricke WA
    Sci Rep; 2024 Jul; 14(1):15736. PubMed ID: 38977751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.
    Tyagi P; Motley SS; Kashyap M; Pore S; Gingrich J; Wang Z; Yoshimura N; Fowke JH
    Int Urol Nephrol; 2015 Jul; 47(7):1051-8. PubMed ID: 25924782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-Specific Deletion of Cdh1 Induces Murine Prostatic Inflammation and Bladder Overactivity.
    Pascal LE; Mizoguchi S; Chen W; Rigatti LH; Igarashi T; Dhir R; Tyagi P; Wu Z; Yang Z; de Groat WC; DeFranco DB; Yoshimura N; Wang Z
    Endocrinology; 2021 Jan; 162(1):. PubMed ID: 33211830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    De Nunzio C; Salonia A; Gacci M; Ficarra V
    World J Urol; 2020 Nov; 38(11):2771-2779. PubMed ID: 32060633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.